ALLISON BEALL: Open Payments
NPI 1518664622 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 19 payments from 5 companies in 2025. Trend: 2023 $370 · 2024 $27 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $147 |
| Novo Nordisk Inc | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Cranial Technologies, Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: QULIPTA, Ozempic, CAPLYTA, VRAYLAR, Doc Band, UBRELVY.
Industry payments across MD — which companies pay providers there.
